Minireviews
Copyright ©The Author(s) 2023.
World J Clin Cases. Jul 16, 2023; 11(20): 4740-4751
Published online Jul 16, 2023. doi: 10.12998/wjcc.v11.i20.4740
Table 2 Probiotics plus eradication therapy: Assessment of probiotic action against H. pylori: Results for Bifidobacterium spp. probiotics
Ref.
Patient characteristics
Type of eradication therapy
Type of probiotic
Results
Çekin et al[54], 2017159 patients with H. pylori infection14-d sequential H. pylori eradication therapyBifidobacterium animalis subsp. lactis B94 1 capsule/d(1) Eradication rates in the probiotic group/placebo group were 86.8% vs 70.8%, P = 0.025; (2) Lower first week diarrhea; and (3) Less common self-reported side effects and higher treatment compliance
Dajani et al[55], 2013377 patientsStandard triple therapy, sequential treatmentBifidus infantis 2036 at 30 × 108 colony-forming units twice dailyEradication rate: Standard therapy-68.9%, probiotic with triple therapy- 83%, pre-treatment before triple therapy-90.5%, probiotic with sequential therapy-90.8% (P < 0.05)